Globus Medical (GMED) Non-Current Deferred Tax Liability (2011 - 2026)
Globus Medical's (GMED) quarterly Non-Current Deferred Tax Liability came in at $24.7 million in Q1 2026, down 47.09% YoY from $46.6 million in Q1 2025, and up 3.8% on a QoQ basis from $23.8 million in Q4 2025.
Globus Medical (GMED) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Globus Medical (GMED) has 16 years of Non-Current Deferred Tax Liability data on file, last reported at $24.7 million in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability fell 47.09% year-over-year to $24.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.7 million (down 47.09% YoY) and the FY2025 annual result came in at $23.8 million, down 0.56% from the prior year.
- Non-Current Deferred Tax Liability improved to $24.7 million in Q1 2026, from $23.8 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $132.2 million in Q3 2023 to a low of $1.4 million in Q1 2023.
- A 5-year average of $27.9 million and a median of $23.8 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability surged 8277.12% — and 2024, when it slumped 94.35%.
- Tracing GMED's Non-Current Deferred Tax Liability over 5 years: stood at $1.8 million in 2022, then jumped by 4645.42% to $84.4 million in 2023, then plunged by 71.7% to $23.9 million in 2024, then declined by 0.56% to $23.8 million in 2025, then climbed by 3.8% to $24.7 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $24.7 million (Q1 2026), $23.8 million (Q4 2025), and $22.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Globus Medical | 11.84 Bn | 11.25 Bn | 548.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.34 Mn |
| Jun 30, 2026 | 42.34 Mn |
| Mar 31, 2026 | 24.66 Mn |
| Mar 31, 2026 | 24.66 Mn |
| Dec 31, 2025 | 23.76 Mn |
| Dec 31, 2025 | 23.76 Mn |
| Sep 30, 2025 | 22.54 Mn |
| Sep 30, 2025 | 22.54 Mn |
| Jun 30, 2025 | 24.40 Mn |
| Jun 30, 2025 | 24.40 Mn |
| Mar 31, 2025 | 46.61 Mn |
| Mar 31, 2025 | 46.61 Mn |
| Dec 31, 2024 | 23.89 Mn |
| Dec 31, 2024 | 23.89 Mn |
| Sep 30, 2024 | 7.48 Mn |
| Sep 30, 2024 | 7.48 Mn |
| Jun 30, 2024 | 27.26 Mn |
| Jun 30, 2024 | 27.26 Mn |
| Mar 31, 2024 | 39.95 Mn |
| Mar 31, 2024 | 39.95 Mn |